The approval of a new drug is a four-stage process: (1) preclinical investigation, (2) clinical investigation, (3) NDA submission and review, and (4) postmarketing studies. Within the second stage (clinical investigation), three phases of trials are conducted over two to ten years. Postmarketing studies, also called postmarketing surveillance, continue in large patient groups during the fourth stage of drug development.
Related Images
1541
1125
1415
10917
1668
658
1209
319
Comments (0)
Explore
Post your homework questions and get free online help from our incredible volunteers
Your Opinion
